TY - JOUR
T1 - Boltzmann’s Theorem Revisited
T2 - Inaccurate Time-to-Action Clocks in Affective Disorders
AU - Ferber, Sari Goldstein
AU - Weller, Aron
AU - Soreq, Hermona
N1 - Publisher Copyright:
© 2024 Bentham Science Publishers.
PY - 2024
Y1 - 2024
N2 - Timely goal-oriented behavior is essential for survival and is shaped by experience. In this paper, a multileveled approach was employed, ranging from the polymorphic level through thermodynamic molecular, cellular, intracellular, extracellular, non-neuronal organelles and electrophysiologi-cal waves, attesting for signal variability. By adopting Boltzmann’s theorem as a thermodynamic con-ceptualization of brain work, we found deviations from excitation-inhibition balance and wave decou-pling, leading to wider signal variability in affective disorders compared to healthy individuals. Recent evidence shows that the overriding on-off design of clock genes paces the accuracy of the multilevel parallel sequencing clocks and that the accuracy of the time-to-action is more crucial for healthy behavioral reactions than their rapidity or delays. In affective disorders, the multilevel clocks run free and lack accuracy of responsivity to environmentally triggered time-to-action as the clock genes are not able to rescue mitochondria organelles from oxidative stress to produce environmentally-triggered energy that is required for the accurate time-to-action and maintenance of the thermodynamic equilib-rium. This maintenance, in turn, is dependent on clock gene transcription of electron transporters, leading to higher signal variability and less signal accuracy in affective disorders. From a Boltzmanni-an thermodynamic and energy-production perspective, the option of reversibility to a healthier time-to-action, reducing entropy is implied. We employed logic gates to show deviations from healthy level-wise communication and the reversed conditions through compensations implying the role of non-neural cells and the extracellular matrix in return to excitation-inhibition balance and accuracy in the time-to-action signaling.
AB - Timely goal-oriented behavior is essential for survival and is shaped by experience. In this paper, a multileveled approach was employed, ranging from the polymorphic level through thermodynamic molecular, cellular, intracellular, extracellular, non-neuronal organelles and electrophysiologi-cal waves, attesting for signal variability. By adopting Boltzmann’s theorem as a thermodynamic con-ceptualization of brain work, we found deviations from excitation-inhibition balance and wave decou-pling, leading to wider signal variability in affective disorders compared to healthy individuals. Recent evidence shows that the overriding on-off design of clock genes paces the accuracy of the multilevel parallel sequencing clocks and that the accuracy of the time-to-action is more crucial for healthy behavioral reactions than their rapidity or delays. In affective disorders, the multilevel clocks run free and lack accuracy of responsivity to environmentally triggered time-to-action as the clock genes are not able to rescue mitochondria organelles from oxidative stress to produce environmentally-triggered energy that is required for the accurate time-to-action and maintenance of the thermodynamic equilib-rium. This maintenance, in turn, is dependent on clock gene transcription of electron transporters, leading to higher signal variability and less signal accuracy in affective disorders. From a Boltzmanni-an thermodynamic and energy-production perspective, the option of reversibility to a healthier time-to-action, reducing entropy is implied. We employed logic gates to show deviations from healthy level-wise communication and the reversed conditions through compensations implying the role of non-neural cells and the extracellular matrix in return to excitation-inhibition balance and accuracy in the time-to-action signaling.
KW - Biological clocks
KW - boltzmann’s theorem
KW - brain timescales
KW - goal-oriented behavior
KW - logic gates
KW - psychopathology
UR - http://www.scopus.com/inward/record.url?scp=85196096669&partnerID=8YFLogxK
U2 - 10.2174/1570159x22666240315100326
DO - 10.2174/1570159x22666240315100326
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 38500272
AN - SCOPUS:85196096669
SN - 1570-159X
VL - 22
SP - 1762
EP - 1777
JO - Current Neuropharmacology
JF - Current Neuropharmacology
IS - 11
ER -